Aberrant crypt foci as biomarkers predictive of colorectal carcinoma;Aberantni kriptni fokusi kot napovedni kazalci kolorektalnega karcinoma

Zdravniski Vestnik

Volumn 79, Issue 6, 2010, Pages 499-506

  Perše, Martina ^a   Mlinarič, Vladimir ^b   Cerar, Anton ^a  

^a INSTITUTE OF PATHOLOGY   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Aberrant crypt focus; Adenoma; Carcinoma; Colorectum; Molecular aberrations

Indexed keywords

EID: 79951890886     PISSN: 13180347     EISSN: 15810224     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Incidenca raka v Sloveniji 2005. Ljubljana: Onkološki inštitut. Register raka za Slovenijo; 2008.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Primic-Žakelj M, Zadnik V, Žagar T. Rak v Sloveniji. Zdrav Vestn 2007; 76: 775-80.
4. Zakotnik B. Mednarodna primerljivost uspešnosti zdravljenja raka v Sloveniji. Zdrav Vestn 2007; 76: 821-6.
5. Ocepek A, Skok P. Chronic Inflammation and Carcinogenesis: An Example of Colorectal Cancer in Inflammatory Bowel Disease. Zdrav Vestn 2008; 77: 629-34.
6. Čufer T. Sistemsko zdravljenje raka: dejstva in pričakovanja. Zdrav Vestn 2007; 76: 801-6.
7. Stevens RG, Swede H, Rosenberg DW. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett 2007; 252: 171-83. (Pubitemid 46809786)
8. Stevens RG, Swede H, Heinen CD, Jablonski M, Grupka M, Ross B, et al. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer. Cancer Lett 2007; 248: 262-8. (Pubitemid 46343762)
9. Takayama T, Ohi M, Hayashi T, Miyanishi K, Nobuoka A, Nakajima T, et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001; 121: 599-611. (Pubitemid 32822575)
10. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998; 339: 1277-84. (Pubitemid 28496193)
11. Bird R P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51. (Pubitemid 17157833)
12. Bird R P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995; 93: 55-71.
13. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000; 112-113: 395-402. (Pubitemid 30138150)
14. Roncucci L, Medline A, Bruce WR. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev 1991; 1: 57-60.
15. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991; 51: 1564-7.
16. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 1993; 85: 2004-7. (Pubitemid 24000983)
17. Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 2005; 1756: 83-96. (Pubitemid 41781960)
18. Fenoglio-Preiser CM, Noffsinger A. Aberrant crypt foci: A review. Toxicol Pathol 1999; 27: 632-42.
19. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, et al. Tumours of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2000: 103.
20. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 2005; 100: 1283-9. (Pubitemid 40904350)
21. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22: 287-94.
22. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-43.
23. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002; 160: 1823-30. (Pubitemid 34525661)
24. Shivapurkar N, Huang L, Ruggeri B, Swalsky PA, Bakker A, Finkelstein S, et al. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett 1997; 115: 39-46. (Pubitemid 27139854)
25. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 1994; 54: 5527-30. (Pubitemid 24346239)
26. Losi L, Roncucci L, Di GC, de Leon MP, Benhattar J. K-ras and p53 mutations in human colorectal aberrant crypt foci. J Pathol 1996; 178: 259-63. (Pubitemid 26120989)
27. Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B, Kinzler K W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54: 5523-6. (Pubitemid 24346238)
28. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130-4. (Pubitemid 28183198)
29. Hao XP, Pretlow TG, Rao JS, Pretlow TP. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res 2001; 61: 419-22. (Pubitemid 32128589)
30. Hao XP, Pretlow TG, Rao JS, Pretlow T P. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 2001; 61: 8085-8. (Pubitemid 33091594)
31. Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, et al. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 2001; 121: 865-74. (Pubitemid 32959396)
32. Kearney KE, Pretlow TG, Pretlow T P. Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention. Int J Cancer 2009; 125: 249-52.
33. Dai CY, Furth EE, Mick R, Koh J, Takayama T, Niitsu Y, et al. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology 2000; 119: 929-42.
34. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res 1996; 56: 5339-41.
35. Luo L, Shen GQ, Stiffler KA, Wang QK, Pretlow TG, Pretlow TP. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 2006; 27: 1153-9. (Pubitemid 43985430)
36. Greenspan EJ, Cyr JL, Pleau DC, Levine J, Rajan T V, Rosenberg DW, Heinen CD. Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis 2007; 28: 769-76. (Pubitemid 46523333)
37. Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, et al. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 2006; 16: 429-35.
38. Rudolph RE, Dominitz JA, Lampe JW, Levy L, Qu P, Li SS, et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev 2005; 14: 605-8. (Pubitemid 40489202)
39. Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D, et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol 2009; 7: 568-74.
40. Gupta AK, Pinsky P, Rall C, Mutch M, Dry S, Seligson D, Schoen RE. Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc 2009; 70: 322-30.
41. Gupta AK, Schoen RE. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol 2009; 25: 59-65.
42. Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, et al. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 2008; 14: 48-54. (Pubitemid 351377977)
43. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, Rajan T V, et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 2007; 67: 3551-4. (Pubitemid 46762136)